Stock Performance Apple SpaceX Stock Ownership Analyst Predictions Price Targets Client Relationships Analyst Ratings Asset Management Sum-of-the-Parts Analysis
Pending Hart-Scott-Rodino approval, AbbVie will integrate Capstan’s Phase 1 CAR-T candidate with its targeted lipid nanoparticle platform for precise RNA delivery.